U.S. Markets closed

RedHill Biopharma Ltd. (RDHL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
7.64-0.12 (-1.55%)
At close: 4:00PM EST

7.63 -0.01 (-0.13%)
After hours: 4:51PM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close7.76
Open7.78
Bid7.59 x 1100
Ask7.63 x 1000
Day's Range7.58 - 7.80
52 Week Range3.26 - 11.35
Volume217,397
Avg. Volume325,625
Market Cap317.724M
Beta (5Y Monthly)1.71
PE Ratio (TTM)N/A
EPS (TTM)-1.80
Earnings DateNov 12, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est22.00
  • RedHill Biopharma Announces Closing of $25 Million Bought Deal Offering
    PR Newswire

    RedHill Biopharma Announces Closing of $25 Million Bought Deal Offering

    RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the closing of its previously announced underwritten offering of 3,188,776 American Depositary Shares (ADSs) of the Company, at a price to the public of $7.84 per ADS. Each ADS represents ten ordinary shares, par value NIS 0.01 per share, of the Company.

  • Why RedHill Biopharma Stock Is Tanking Today
    Motley Fool

    Why RedHill Biopharma Stock Is Tanking Today

    The decline came after the specialty biopharmaceutical company announced that it was increasing the size of its previously announced public stock offering. RedHill now plans to offer nearly 3.2 million American depositary shares (ADSs) at a price of $7.84 per share. There's good news and bad news with RedHill's decision to increase the size of its public stock offering.

  • RedHill Biopharma Increases Previously Announced Bought Deal to $25 Million
    PR Newswire

    RedHill Biopharma Increases Previously Announced Bought Deal to $25 Million

    RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that due to demand, the underwriter has agreed to increase the size of the previously announced offering and purchase on a firm commitment basis 3,188,776 American Depositary Shares (ADSs) of the Company, at a price to the public of $7.84 per ADS, less underwriting discounts and commissions. Each ADS represents ten ordinary shares, par value NIS 0.01 per share, of the Company. The closing of the offering is expected to occur on or about January 14, 2021, subject to satisfaction of customary closing conditions.